Cargando…
Recurrence of Graves’ Disease: What Genetics of HLA and PTPN22 Can Tell Us
BACKGROUND: Approximately half of patients diagnosed with Graves’ disease (GD) relapse within two years of thyreostatic drug withdrawal. It is then necessary to decide whether to reintroduce conservative treatment that can have serious side effects, or to choose a radical approach. Familial forms of...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650699/ https://www.ncbi.nlm.nih.gov/pubmed/34887833 http://dx.doi.org/10.3389/fendo.2021.761077 |